Snap Chart
Weight-loss Drugs Aren't Just Changing Waistlines
A Bain survey shows GLP-1 drugs, like those known as Ozempic or Wegovy, lead to significant changes in consumer behavior that often persist even after consumers stop taking them.
About the Research
Data powered by Dynata, a leading global first-party data and insights platform.
Industry Expertise
Explore Bain's expertise in Consumer Products and learn how we can help your company.
LEARN MORE
First published in Δεκέμβριος 2024